|
Fresenius Kabi India On Expansion Spree
Fresenius Kabi India, a wholly-owned subsidiary of Germany-based Fresenius
Kabi, has decided to aggressively expand its operation both through organic and
inorganic routes. The more than Rs 100-crore company, based in Pune, is a
leading provider of plasma volume expanders and parenteral nutrition solutions.
"We are currently expanding operations in China and once we gain a strong
foothold there, we’ll turn attention to India," said Rakesh Bhargava, managing
director and chief executive officer of Fresenius Kabi India.
As part of its initiatives to spread out in the Indian pharma market, the
company recently launched blood banking products and enteral nutrition powder
diets, besides a couple of parenteral and enteral nutrition packages. Fresenius
Kabi India is already a major player in this segment. It’s nutrition products
are used in four major areas - ICU, post-operative, oncology and
gastroenterology. "Outside the US and Japan, the company has established itself
as the number one provider of nutrition products," Bhargava claimed.
Fresenius Kabi India has WHO-GMP certified state-of-the-art factory in Pune
for manufacturing plasma volume expanders, intra-venous drugs and basic
intra-venous solutions. This facility has also obtained approval from European
regulatory authorities to export its products to Europe.
As regards oncology products, Bhargava said the company offers a wide range
of products especially suited for the dietary management of cancer patients for
the improvement of their nutritional status. Fresenius Kabi has products such as
omegaven and dipeptiven in its kitty, strengthening its presence in parenteral
nutrition segment.
(Ref: The Economic Times dated August 12, 2007)
Poly Medicure To Set Up New Facility In Haryana, Investing Rs 25 Crore
Poly Medicure Ltd, manufacturer and supplier of wide range of disposable medical
and surgical devices, is planning to expand the reach by investing Rs 25 crore
and setting up another facility at Ballabgarh in Haryana.
The Rs 100-crore entity has its new manufacturing facility at Uttaranchal
already started functioning from June this year. It has units in Faridabad,
Jaipur and Egypt (in collaboration with a partner).
The company, which is on a mode of expansion by consolidating the manufacturing
and entering into tie-ups, has already acquired US company last year and applied
for 3 patents and two US FDA approvals for its safety, according to managing
director Himanshu Baid.
"Polymed is growing at a rate of 40% (domestic) compared to the industry growth
of 10-15%. Polymed is also expanding its present capacity of 130 million units
to 180 million with the capital expenditure of Rs 25 crore to cater to the
burgeoning demand in the domestic and international market," he said.
Polymed is now focusing on tie-ups with large hospital groups in the country to
increase presence in the domestic Market. Polymed manufactures more than 40
different products under different categories like IV Cannulaes, infusion
therapy devices, central venous access catheters, anaesthesia, blood management
devices and other surgical products. The company is already exporting its range
of products to more than 50 countries across different continents including
Europe/Africa/Asia and South America.
It has successfully implemented a quality management system and has been
accredited by SGS Yarsley International Certification Services, United Kingdom
with ISO 9001:2000, ISO-13488:1996 and CE mark for some of its products, the
company has been accredited CE mark by DNV, Norway thus making the entire
product range match up to international quality standards.
(Ref: Chronicle Pharmabiz dated August 9, 2007)
|
